Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 7, 2010, Pages 3268-3271

  Wallace, I R ^a   Satti, N ^a   Courtney, C H ^a   Leslie, H ^a   Bell, P M ^a   Hunter, S J ^a   McCance, D R ^a   Sheridan, B ^a   Atkinson, A Brew ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MACROGOL; PROLACTIN;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GALACTORRHEA; HEADACHE; HOMONYMOUS HEMIANOPIA; HUMAN; HYPERPROLACTINEMIA; MACROPROLACTINEMIA; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; OLIGOMENORRHEA; PRECIPITATION; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; VISUAL ACUITY; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; PREGNANCY;

ADULT; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; HUMANS; HYPERPROLACTINEMIA; PREGNANCY; PROLACTIN;

EID: 77954910025     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0114     Document Type: Article

References (20)

1. Smith CR, Norman MR 1990 Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann Clin Biochem 27:542-550 (Pubitemid 20377171)
2. Leite V, Cosby H, Sobrinho LG, Fresnoza MA, Santos MA, Friesen HG 1992 Characterization of big big prolactin in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) 37:365-372
3. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H 1994 Correlation of the antibody titres with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody. Eur J Endocrinol 130:438-445 (Pubitemid 24165768)
4. Bjøro T, Mørkrid L, Wergeland R, Turter A, Kvistborg A, Sand T, Torjesen P 1995 Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 55:139-147
5. Hattori N, Ishihara T, Saiki Y 2009 Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers. Clin Endocrinol (Oxf) 71:702-708
6. Leslie H, Courtney CH, Bell PM, Hadden DR, McCance DR, Ellis PK, Sheridan B, Atkinson AB 2001 Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743-2746 (Pubitemid 32545732)
7. Olukoga AO, Kane JW 1999 Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol (Oxf) 51:119-126
8. Fahie-Wilson MN, Soule SG 1997 Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34:252-258
9. Vieira JG, Tachibana TT, Obara LH, Maciel RM 1998 Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinaemia. Clin Chem 44:1758-1759
10. Smith TP, Suliman AM, Fahie-Wilson MN, McKenna TJ 2002 Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410-5415
11. Vallette-Kasic S, Morange-Ramos I, Selim A, Gunz G, Morange S, Enjalbert A, Martin PM, Jaquet P, Brue T 2002 Macroprolactinemia revisited: a study on 106 patients. J Clin Endocrinol Metab 87:581-588 (Pubitemid 34158222)
12. Suliman AM, Smith TP, Gibney J, McKenna TJ 2003 Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49:1504-1509 (Pubitemid 37011739)
13. Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro Jr R, Barros AI, Faria M, Nascimento GC, Lima JG, Nóbrega LH, Cruz TP, Mota A, Ramos A, Violante A, Lamounier Filho A, Gadelha MR, Czepielewski MA, Glezer A, Bronstein MD 2008 Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest 31:436-444
14. Kavanagh-Wright L, Smith TP, Gibney J, McKenna TJ 2009 Characterization of macroprolactin and assessment of markers of autoimmunity in macroprolactinaemic patients. Clin Endocrinol (Oxf) 70:599-605
15. Vanderpump MP, French JM, Appleton D, Tunbridge WM, Kendall-Taylor P 1998 The prevalence of hyperprolactinaemia and association with markers of autoimmune thyroid disease in survivors of the Wickham Survey cohort. Clin Endocrinol (Oxf) 48:39-44 (Pubitemid 28122431)
16. Fahie-Wilson M 2003 In hyperprolactinaemia, testing for macroprolactin is essential. Clin Chem 49:1434-1436
17. Fahie-Wilson MN, Ahlquist JA 2003 Hyperprolactinaemia due to macroprolactins: some progress but still a problem. Clin Endocrinol (Oxf) 58:683-685
18. Gibney J, Smith TP, McKenna TJ 2005 Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 62:633-643
19. McKenna TJ 2009 Should macroprolactin be measured in all hyperprolactinaemic sera. Clin Endocrinol (Oxf) 71:466-469
20. Gibney J, Smith TP, McKenna TJ 2005 The impact on clinical practice of routine screening for macroprolactin. J Clin Endocrinol Metab 90:3927-3932 (Pubitemid 41058153)